Haleon plc
Haleon plc is a consumer health company focused on everyday self-care and over-the-counter wellness products. Its portfolio includes oral health, vitamins and supplements, pain relief, respiratory, digestive and therapeutic skin health brands sold through retail and healthcare channels across global markets. It is listed in London and New York and operates as a standalone consumer health group.
Fiscal year 2025 · change from previous year
Development 2022–2025
Business
Share of revenueToothpaste, mouthwash and denture-care brands for daily oral care.
Analgesics and related products used for headache, muscle and fever relief.
Nutritional supplements and multivitamins for everyday health support.
Products used for congestion, cold and flu symptom relief.
Over-the-counter products for digestive comfort and gastrointestinal support.
Skin-health treatments and smaller adjacent consumer health categories.
Customers
Haleon sells primarily to consumers through pharmacies, drugstores, mass retail and e-commerce, with products chosen for self-care, symptom relief and routine wellness. A meaningful part of demand is also influenced by healthcare professionals and pharmacists, who recommend trusted branded products such as Sensodyne, Voltaren and Centrum. The business serves both prescription-adjacent and pure over-the-counter usage occasions, which makes brand credibility and shelf presence important.
Buy OTC health and wellness products for daily use, symptom relief and prevention.
Influence product choice by recommending oral care, pain relief and respiratory brands.
Purchase Haleon brands for shelf placement and repeat consumer demand.
Stock mainstream health brands that benefit from broad household penetration.
Sell branded health products online to convenience-focused consumers.
Strategy
Haleon's strategy is centered on brand-led consumer health categories where trust, recommendation and repeat purchase matter. The company emphasizes innovation, research and investment in priority categories while balancing growth investment, acquisitions optionality and a strong credit profile. Its portfolio structure is designed to support scale in daily-use health brands across retail and healthcare channels.
Scale and brand trust drive repeat purchasing and pharmacy recommendation.
New formats and claims help sustain relevance in crowded OTC categories.
A moderate leverage profile supports growth investment and shareholder returns.
Geography
Haleon sells in multiple regions through a globally distributed consumer health platform, with international brands that are recognized in both developed and emerging markets. Its operating footprint spans the UK-listed corporate base, the US capital markets listing and a broad international commercial network. Geography matters because local regulation, consumer preferences and pharmacy-channel access affect brand mix and demand.
Risks
Haleon's main risks are competitive pressure in branded OTC categories, where consumer switching and retailer bargaining power can affect market share and shelf presence. The business is also exposed to regulatory and product-safety scrutiny because its brands sit in health-related categories sold across many jurisdictions. Global supply chain disruption, foreign exchange volatility and dependence on brand trust are additional industry-typical risks.
- Competition in OTC health categoriesImpact: HighLikelihood: High
Consumers and pharmacies can switch among branded and private-label alternatives.
Exposure - Regulatory and product-safety exposureImpact: HighLikelihood: Medium
Consumer health products are subject to rules on claims, ingredients and labeling.
Exposure: global consumer health portfolio
- Foreign exchange volatilityImpact: MediumLikelihood: High
International sales and costs create translation and transaction exposure.
Exposure: multi-currency global operations
- Supply chain disruptionImpact: MediumLikelihood: Medium
Manufacturing and distribution issues can limit product availability and service levels.
Exposure: global sourcing and distribution network
Accounting
Judgemental itemsManagement uses adjusted EBITDA, operating profit and margin measures that exclude non-comparable items.
Impact: Affects comparability with IFRS results and peer valuation multiples.
A consumer health portfolio built on brands requires impairment testing and judgment.
Impact: Can create large non-cash charges if brand values weaken.
International operations create translation effects in reported revenue and profit.
Impact: Can obscure underlying volume and pricing trends.
Health-related businesses may face warranty, legal or other contingent liabilities.
Impact: Changes can shift period earnings materially.
Similar listed companies
Publicly listed companies with a comparable business focus.
PERRIGO Co plc
PRGO · Pharmaceutical Preparations
Perrigo Co plc is a consumer self-care company focused on over-the-counter health and wellness products sold through retail and pharmacy channels.
Kenvue Inc.
KVUE · Perfumes, Cosmetics & Other Toilet Preparations
Heron Therapeutics, Inc
HRTX · Pharmaceutical Preparations
Heron Therapeutics is a U.S.-based commercial-stage biotechnology company focused on acute care and oncology supportive care products.
Medtronic plc
MDT · Electromedical & Electrotherapeutic Apparatus
Medtronic plc designs, manufactures, and sells medical technologies used to diagnose, treat, and manage chronic and acute conditions across the body.
Teladoc Health, Inc.
TDOC · Services-Offices & Clinics of Doctors of Medicine
Davion Healthcare PLC
DAVI · Surgical & Medical Instruments & Apparatus
Davion Healthcare Plc is an Ireland-based healthcare company focused on developing and commercialising healthcare technologies and products.
Last updated: 28/09/2026